209 related articles for article (PubMed ID: 8836905)
1. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.
Gerling B; Becker M; Waldschmidt J; Rehmann M; Schuppan D
J Hepatol; 1996 Jul; 25(1):79-84. PubMed ID: 8836905
[TBL] [Abstract][Full Text] [Related]
2. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
3. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis.
Hayasaka A; Koch J; Schuppan D; Maddrey WC; Hahn EG
J Hepatol; 1991 Nov; 13(3):328-38. PubMed ID: 1725528
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay for serum procollagen type III peptide in rats with hepatic fibrosis.
Cho JJ; Lee YS
J Vet Med Sci; 1998 Nov; 60(11):1213-20. PubMed ID: 9853302
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis.
Raetsch C; Jia JD; Boigk G; Bauer M; Hahn EG; Riecken EO; Schuppan D
Gut; 2002 Feb; 50(2):241-7. PubMed ID: 11788567
[TBL] [Abstract][Full Text] [Related]
6. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
Ruf G; Mappes HJ; Koch H; Baumgartner U; Hagmann W; Farthmann EH
Hepatogastroenterology; 1996; 43(7):121-6. PubMed ID: 8682446
[TBL] [Abstract][Full Text] [Related]
7. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat.
Ruwart MJ; Wilkinson KF; Rush BD; Vidmar TJ; Peters KM; Henley KS; Appelman HD; Kim KY; Schuppan D; Hahn EG
Hepatology; 1989 Nov; 10(5):801-6. PubMed ID: 2807158
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis.
Schuppan D; Dumont JM; Kim KY; Hennings G; Hahn EG
J Hepatol; 1986; 3(1):27-37. PubMed ID: 3745883
[TBL] [Abstract][Full Text] [Related]
9. Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen.
Ala-Kokko L; Günzler V; Hoek JB; Rubin E; Prockop DJ
Hepatology; 1992 Jul; 16(1):167-72. PubMed ID: 1618469
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of theophylline: effects of hepatic fibrosis in rats induced bile duct ligation.
Han SS; Kim KY; Ham SH; Sohn DH; Kim JB
Biol Pharm Bull; 1995 Mar; 18(3):470-3. PubMed ID: 7550107
[TBL] [Abstract][Full Text] [Related]
11. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis.
Cho JJ; Hocher B; Herbst H; Jia JD; Ruehl M; Hahn EG; Riecken EO; Schuppan D
Gastroenterology; 2000 Jun; 118(6):1169-78. PubMed ID: 10833492
[TBL] [Abstract][Full Text] [Related]
12. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
[TBL] [Abstract][Full Text] [Related]
13. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
14. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
15. Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis.
Hironaka K; Sakaida I; Uchida K; Okita K
Dig Dis Sci; 2000 Oct; 45(10):1935-43. PubMed ID: 11117563
[TBL] [Abstract][Full Text] [Related]
16. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
Murawaki Y; Ikuta Y; Koda M; Kawasaki H
Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.
Jia JD; Bauer M; Cho JJ; Ruehl M; Milani S; Boigk G; Riecken EO; Schuppan D
J Hepatol; 2001 Sep; 35(3):392-8. PubMed ID: 11592601
[TBL] [Abstract][Full Text] [Related]
18. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
19. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
20. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
